Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Wearable Patch Market, by Technology
1.4.2 North America Wearable Patch Market, by Application
1.4.3 North America Wearable Patch Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Approvals
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions : 2016, Feb – 2020, Sep) Leading Players
Chapter 4. North America Wearable Patch Market by Technology
4.1 North America Connected Wearable Market by Country
4.2 North America Regular Wearable Market by Country
Chapter 5. North America Wearable Patch Market by Application
5.1 North America Non-Clinical Market by Country
5.2 North America Clinical Market by Country
Chapter 6. North America Wearable Patch Market by Country
6.1 USA Wearable Patch Market
6.1.1 USA Wearable Patch Market by Technology
6.1.2 USA Wearable Patch Market by Application
6.2 Canada Wearable Patch Market
6.2.1 Canada Wearable Patch Market by Technology
6.2.2 Canada Wearable Patch Market by Application
6.3 Mexico Wearable Patch Market
6.3.1 Mexico Wearable Patch Market by Technology
6.3.2 Mexico Wearable Patch Market by Application
6.4 Rest of North America Wearable Patch Market
6.4.1 Rest of North America Wearable Patch Market by Technology
6.4.2 Rest of North America Wearable Patch Market by Application
Chapter 7. Company Profiles
7.1 DexCom, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.1.5.2 Product Launches and Product Expansions:
7.2 Abbott Laboratories
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.1 Recent strategies and developments:
7.2.1.1 Partnerships, Collaborations, and Agreements:
7.2.1.2 Product Launches and Product Expansions:
7.3 Koninklijke Philips N.V.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expenses
7.3.5 Recent strategies and developments:
7.3.5.1 Product Launches and Product Expansions:
7.3.5.2 Approvals:
7.4 Smith & Nephew PLC (Leaf Healthcare, Inc.)
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.5 Qualcomm, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Product Launches and Product Expansions:
7.6 L'Oreal Group
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.6.5 Recent strategies and developments:
7.6.5.1 Product Launches and Product Expansions:
7.6.5.2 Partnerships, Collaborations, and Agreements:
7.7 VivaLNK, Inc.
7.7.1 Company Overview
7.7.2 Recent strategies and developments:
7.7.2.1 Partnerships, Collaborations, and Agreements:
7.7.2.2 Product Launches and Product Expansions:
7.7.2.3 Approvals:
7.8 Cardiac Insight, Inc.
7.8.1 Company Overview
7.8.2 Recent strategies and developments:
7.8.2.1 Product Launches and Product Expansions:
7.8.2.2 Approvals:
7.9 AliveCor, Inc.
7.9.1 Company Overview
7.9.2 Recent strategies and developments:
7.9.2.1 Approvals:
7.10. LifeSignals Group, Inc.
7.10.1 Company Overview
7.10.2 Recent strategies and developments:
7.10.2.1 Product Launches and Product Expansions:
7.10.2.2 Approvals:
Unique Offerings 